Please wait while the formulary information is being retrieved.
CAPASTAT SULFATE (CAPREOMYCIN SULFATE)
- Active tuberculosis
- Pulmonary tuberculosis
Capastat 1 gram solution for injection
- Infuse 1 gram by intravenous route once daily for 60 days
Pulmonary tuberculosis
- Inject 1 gram by intramuscular route twice weekly
- Inject 1 gram by intramuscular route 3 times per week
- Infuse 1 gram by intravenous route once daily for 60 days
- Infuse 1 gram by intravenous route once daily for 120 days
- Inject 1 gram by intramuscular route once daily for 60 days
- Inject 1 gram by intramuscular route once daily for 120 days
- Infuse 1 gram over 60 minute(s) by intravenous route twice weekly
- Infuse 1 gram over 60 minute(s) by intravenous route 3 times per week
- cidofovir
- typhoid vaccine
- Vistide
- Vivotif Berna Vaccine
Contraindicated
- BCG live
- BCG vaccine, live (PF)
- Tice Bcg
Severe
Moderate
- abobotulinumtoxinA
- adefovir
- Anectine
- atracurium
- Atripla
- Botox
- Botox Cosmetic
- cisatracurium
- Complera
- Dysport
- efavirenz-emtricitabin-tenofov
- elvitegr-cobicist-emtric-tenof
- emtricitab-rilpivirine-tenofov
- emtricitabine-tenofovir
- Hepsera
- incobotulinumtoxinA
- Myobloc
- Nimbex
- onabotulinumtoxinA
- pancuronium
- Quelicin
- rimabotulinumtoxinB
- rocuronium
- Stribild
- succinylcholine chloride
- tenofovir disoproxil fumarate
- Truvada
- vecuronium bromide
- Viread
- Xeomin
- Zemuron
- None
Contraindicated
- Disorder of the 8th cranial nerve
- Hearing loss
- Kidney disease with reduction in GFR
Severe
Moderate
- Dehydration
- Disease of liver
- Hypokalemia
CAPASTAT SULFATE (CAPREOMYCIN SULFATE)
- Active tuberculosis
- Pulmonary tuberculosis
- Nephrotoxicity
- None
More Frequent
Severe
Less Severe
- Allergic dermatitis
- Angioedema
- Erythema
- Hypokalemia
- Injection site sequelae
- Neuromuscular blockade
- Pruritus of skin
- Skin rash
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Hearing loss
- Hypocalcemia
- Hypomagnesemia
- Maculopapular rash
- Urticaria
Less Severe
- Leukocytosis
- Leukopenia
Contraindicated
None
Severe Precaution
Capreomycin
Safety and efficacy not established in pediatrics. Risk of nephrotoxicity, cranial nerve injury.
- 1 Day – 18 Years
- Safety and efficacy not established in pediatrics. Risk of nephrotoxicity, cranial nerve injury.
Management or Monitoring Precaution
None
Capreomycin Sulfate
- Severity Level:
C
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
Capreomycin
Minimal risk to infant; less than 1% of oral drug absorbed systemically
General | Excretion Potential | Effect on Infant | Notes |
No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Minimal risk to infant; less than 1% of oral drug absorbed systemically |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- Use capreomycin with extreme caution in people with hearing or kidney problems and in those using other drugs that may cause hearing or kidney problems (see Drug Interactions section). Other injectable medications used to treat tuberculosis (e.g., streptomycin) should not be used with capreomycin because they will increase the risk of hearing and kidney problems.
Active tuberculosis | |
A15 | Respiratory tuberculosis |
A15.0 | Tuberculosis of lung |
A15.4 | Tuberculosis of intrathoracic lymph nodes |
A15.5 | Tuberculosis of larynx, trachea and bronchus |
A15.6 | Tuberculous pleurisy |
A15.7 | Primary respiratory tuberculosis |
A15.8 | Other respiratory tuberculosis |
A15.9 | Respiratory tuberculosis unspecified |
A17 | Tuberculosis of nervous system |
A17.0 | Tuberculous meningitis |
A17.1 | Meningeal tuberculoma |
A17.8 | Other tuberculosis of nervous system |
A17.81 | Tuberculoma of brain and spinal cord |
A17.82 | Tuberculous meningoencephalitis |
A17.83 | Tuberculous neuritis |
A17.89 | Other tuberculosis of nervous system |
A17.9 | Tuberculosis of nervous system, unspecified |
A18 | Tuberculosis of other organs |
A18.0 | Tuberculosis of bones and joints |
A18.01 | Tuberculosis of spine |
A18.02 | Tuberculous arthritis of other joints |
A18.03 | Tuberculosis of other bones |
A18.09 | Other musculoskeletal tuberculosis |
A18.1 | Tuberculosis of genitourinary system |
A18.10 | Tuberculosis of genitourinary system, unspecified |
A18.11 | Tuberculosis of kidney and ureter |
A18.12 | Tuberculosis of bladder |
A18.13 | Tuberculosis of other urinary organs |
A18.14 | Tuberculosis of prostate |
A18.15 | Tuberculosis of other male genital organs |
A18.16 | Tuberculosis of cervix |
A18.17 | Tuberculous female pelvic inflammatory disease |
A18.18 | Tuberculosis of other female genital organs |
A18.2 | Tuberculous peripheral lymphadenopathy |
A18.3 | Tuberculosis of intestines, peritoneum and mesenteric glands |
A18.31 | Tuberculous peritonitis |
A18.32 | Tuberculous enteritis |
A18.39 | Retroperitoneal tuberculosis |
A18.4 | Tuberculosis of skin and subcutaneous tissue |
A18.5 | Tuberculosis of eye |
A18.50 | Tuberculosis of eye, unspecified |
A18.51 | Tuberculous episcleritis |
A18.52 | Tuberculous keratitis |
A18.53 | Tuberculous chorioretinitis |
A18.54 | Tuberculous iridocyclitis |
A18.59 | Other tuberculosis of eye |
A18.6 | Tuberculosis of (inner) (middle) ear |
A18.7 | Tuberculosis of adrenal glands |
A18.8 | Tuberculosis of other specified organs |
A18.81 | Tuberculosis of thyroid gland |
A18.82 | Tuberculosis of other endocrine glands |
A18.83 | Tuberculosis of digestive tract organs, not elsewhere classified |
A18.84 | Tuberculosis of heart |
A18.85 | Tuberculosis of spleen |
A18.89 | Tuberculosis of other sites |
A19 | Miliary tuberculosis |
A19.0 | Acute miliary tuberculosis of a single specified site |
A19.1 | Acute miliary tuberculosis of multiple sites |
A19.2 | Acute miliary tuberculosis, unspecified |
A19.8 | Other miliary tuberculosis |
A19.9 | Miliary tuberculosis, unspecified |
O98.0 | Tuberculosis complicating pregnancy, childbirth and the puerperium |
O98.01 | Tuberculosis complicating pregnancy |
O98.011 | Tuberculosis complicating pregnancy, first trimester |
O98.012 | Tuberculosis complicating pregnancy, second trimester |
O98.013 | Tuberculosis complicating pregnancy, third trimester |
O98.019 | Tuberculosis complicating pregnancy, unspecified trimester |
O98.02 | Tuberculosis complicating childbirth |
O98.03 | Tuberculosis complicating the puerperium |
P37.0 | Congenital tuberculosis |
Pulmonary tuberculosis | |
A15 | Respiratory tuberculosis |
A15.0 | Tuberculosis of lung |
A15.7 | Primary respiratory tuberculosis |
A15.8 | Other respiratory tuberculosis |
0-9 | A-Z |
---|---|
A15 | Respiratory tuberculosis |
A15 | Respiratory tuberculosis |
A15.0 | Tuberculosis of lung |
A15.0 | Tuberculosis of lung |
A15.4 | Tuberculosis of intrathoracic lymph nodes |
A15.5 | Tuberculosis of larynx, trachea and bronchus |
A15.6 | Tuberculous pleurisy |
A15.7 | Primary respiratory tuberculosis |
A15.7 | Primary respiratory tuberculosis |
A15.8 | Other respiratory tuberculosis |
A15.8 | Other respiratory tuberculosis |
A15.9 | Respiratory tuberculosis unspecified |
A17 | Tuberculosis of nervous system |
A17.0 | Tuberculous meningitis |
A17.1 | Meningeal tuberculoma |
A17.8 | Other tuberculosis of nervous system |
A17.81 | Tuberculoma of brain and spinal cord |
A17.82 | Tuberculous meningoencephalitis |
A17.83 | Tuberculous neuritis |
A17.89 | Other tuberculosis of nervous system |
A17.9 | Tuberculosis of nervous system, unspecified |
A18 | Tuberculosis of other organs |
A18.0 | Tuberculosis of bones and joints |
A18.01 | Tuberculosis of spine |
A18.02 | Tuberculous arthritis of other joints |
A18.03 | Tuberculosis of other bones |
A18.09 | Other musculoskeletal tuberculosis |
A18.1 | Tuberculosis of genitourinary system |
A18.10 | Tuberculosis of genitourinary system, unspecified |
A18.11 | Tuberculosis of kidney and ureter |
A18.12 | Tuberculosis of bladder |
A18.13 | Tuberculosis of other urinary organs |
A18.14 | Tuberculosis of prostate |
A18.15 | Tuberculosis of other male genital organs |
A18.16 | Tuberculosis of cervix |
A18.17 | Tuberculous female pelvic inflammatory disease |
A18.18 | Tuberculosis of other female genital organs |
A18.2 | Tuberculous peripheral lymphadenopathy |
A18.3 | Tuberculosis of intestines, peritoneum and mesenteric glands |
A18.31 | Tuberculous peritonitis |
A18.32 | Tuberculous enteritis |
A18.39 | Retroperitoneal tuberculosis |
A18.4 | Tuberculosis of skin and subcutaneous tissue |
A18.5 | Tuberculosis of eye |
A18.50 | Tuberculosis of eye, unspecified |
A18.51 | Tuberculous episcleritis |
A18.52 | Tuberculous keratitis |
A18.53 | Tuberculous chorioretinitis |
A18.54 | Tuberculous iridocyclitis |
A18.59 | Other tuberculosis of eye |
A18.6 | Tuberculosis of (inner) (middle) ear |
A18.7 | Tuberculosis of adrenal glands |
A18.8 | Tuberculosis of other specified organs |
A18.81 | Tuberculosis of thyroid gland |
A18.82 | Tuberculosis of other endocrine glands |
A18.83 | Tuberculosis of digestive tract organs, not elsewhere classified |
A18.84 | Tuberculosis of heart |
A18.85 | Tuberculosis of spleen |
A18.89 | Tuberculosis of other sites |
A19 | Miliary tuberculosis |
A19.0 | Acute miliary tuberculosis of a single specified site |
A19.1 | Acute miliary tuberculosis of multiple sites |
A19.2 | Acute miliary tuberculosis, unspecified |
A19.8 | Other miliary tuberculosis |
A19.9 | Miliary tuberculosis, unspecified |
O98.0 | Tuberculosis complicating pregnancy, childbirth and the puerperium |
O98.01 | Tuberculosis complicating pregnancy |
O98.011 | Tuberculosis complicating pregnancy, first trimester |
O98.012 | Tuberculosis complicating pregnancy, second trimester |
O98.013 | Tuberculosis complicating pregnancy, third trimester |
O98.019 | Tuberculosis complicating pregnancy, unspecified trimester |
O98.02 | Tuberculosis complicating childbirth |
O98.03 | Tuberculosis complicating the puerperium |
P37.0 | Congenital tuberculosis |
Formulary Reference Tool